Show
Sort by
-
Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression
-
A JAK3/STAT3 passenger activation in a lapatinib-acquired resistance model of HER2-amplified breast cancer
-
Second hit landscape in BRCA-associated breast cancer
-
Comparative analysis of cervical cytology and human papillomavirus genotyping by three different methods in a routine diagnostic setting
-
2013 Update of the American Society of Clinical Oncology/College of American Pathologists guideline for human epidermal growth factor receptor 2 testing: impact on immunohistochemistry-negative breast cancers
-
Stromal characteristics are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ (DCIS)
-
Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype
-
Lymphoplasmacytic lymphoma exposed by haemoptysis and acquired von Willebrand syndrome
-
HER2 status in breast cancer : an in-depth pathobiological analysis
(2014) -
Cancer-associated adipose tissue promotes breast cancer progression by paracrine Oncostatin M and JAK3/STAT3 signaling